New prognostic index based on the EFS24 for patients with DLBCL in the rituximab era

Koh Izumiyama

Presentation information

Poster Session

Sun. Oct, 14

Poster Session 3-16 DLBCL: Prognostic factors

Sun. Oct 14, 2018 1:00 PM - 1:40 PM Poster2 (Osaka International Convention Center, 5F Main Foyer)

Chair: Hideki Tsujimura (Chiba Cancer Center)

[PS3-16-7] New prognostic index based on the EFS24 for patients with DLBCL in the rituximab era

Koh Izumiyama¹, Koichiro Minauchi², Hajime Senjo^1,2, Reiki Ogasawara¹, Minoru Kanaya¹, Akio Mori¹, Takeshi Kondo¹, Makoto Saito¹, Masanori Tanaka¹, Masanobu Morioka¹ (1.Dept. Hematol., Aiiku Hospital, Sapporo, Japan, 2.Dept., Hematol., Sapporo Hokuyu Hospital, Sapporo, Japan)

Abstract password authentication.
Password is written on a program and abstract book.